Lee Jae Sun, Kim Yun Na, Kim Na-Hyun, Heo Jeong-Doo, Yang Min Hye, Rho Jung-Rae, Jeong Eun Ju
Department of Agronomy and Medicinal Plant Resources, Gyeongnam National University of Science and Technology, Jinju 52725, Republic of Korea.
Gyeongnam Department of Environment and Toxicology, Korea Institute of Toxicology, Gyeongnam 52834, Republic of Korea.
Pharmacogn Mag. 2017 Oct-Dec;13(52):535-541. doi: 10.4103/pm.pm_477_16. Epub 2017 Nov 13.
, a naturally salt-tolerant halophyte, has been studied recently and is of much interest to researchers due to its potent antioxidant and hepatoprotective activities.
In the present study, we attempted to elucidate bioactive compounds from ethyl acetate (EtOAc) soluble fraction of extract. Furthermore, the simultaneous analysis method of bioactive EtOAc fraction of has been developed using high-performance liquid chromatography (HPLC).
Thirteen compounds have been successfully isolated from EtOAc fraction of , and the structures of 1-13 were elucidated by extensive one-dimensional and two-dimensional spectroscopic methods including H-NMR, C-NMR, H-H COSY, heteronuclear single quantum coherence, heteronuclear multiple bond correlation, and nuclear Overhauser effect spectroscopy. Hepatoprotection of the isolated compounds against liver fibrosis was evaluated by measuring inhibition on hepatic stellate cells (HSCs) undergoing proliferation.
Compounds 1-13 were identified as gallincin (1), apigenin-3-O-β-D-galactopyranoside (2), quercetin (3), quercetin-3-O-β-D-galactopyranoside (4), (-)-epigallocatechin (5), (-)-epigallocatechin-3-gallate (6), (-)-epigallocatechin-3-(3″-O-methyl) gallate (7), myricetin-3-O-β-D-galactopyranoside (8), myricetin-3-O-(6″-O-galloyl)-β-D-galactopyranoside (9), myricetin-3-O-α-L-rhamnopyranoside (10), myricetin-3-O-(2″-O-galloyl)-α-L-rhamnopyranoside (11), myricetin-3-O-(3″-O-galloyl)-α-L-rhamnopyranoside (12), and myricetin-3-O-α-L-arabinopyranoside (13), respectively. All compounds except for 4, 8, and 10 are reported for the first time from this plant.
Myricetin glycosides which possess galloyl substituent (9, 11, and 12) showed most potent inhibitory effects on the proliferation of HSCs.
In the present study, we have successfully isolated 13 compounds from bioactive fraction of . The structures of compounds isolated have been fully elucidated, and hepatoprotective activities of compounds against liver fibrosis were evaluated by measuring inhibition on hepatic stellate cells undergoing proliferation. Furthermore, the simultaneous analysis method of bioactive ethyl acetate fraction of has been developed using HPLC. Ten compounds identified herein are reported for the first time from this plant. HSQC: Heteronuclear single quantum coherence; HMBC: Heteronuclear multiple bond correlation; NOESY: Nuclear Overhauser effect spectroscopy; EGCG: Epigallocatechin-3-gallate; EGC: Epigallocatechin; HSC: Hepatic stellate cell; MTT: 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide.
[植物名称]是一种天然耐盐的盐生植物,近年来受到研究关注,因其具有强大的抗氧化和肝脏保护活性。
在本研究中,我们试图阐明[植物名称]提取物乙酸乙酯(EtOAc)可溶部分中的生物活性化合物。此外,已开发出使用高效液相色谱(HPLC)对[植物名称]的生物活性EtOAc部分进行同步分析的方法。
已从[植物名称]的EtOAc部分成功分离出13种化合物,并通过广泛的一维和二维光谱方法(包括¹H-NMR、¹³C-NMR、¹H-¹H COSY、异核单量子相干、异核多键相关和核Overhauser效应光谱)阐明了1-13号化合物的结构。通过测量对正在增殖的肝星状细胞(HSCs)的抑制作用,评估分离出的化合物对肝纤维化的肝脏保护作用。
化合物1-13分别被鉴定为没食子素(1)、芹菜素-3-O-β-D-吡喃半乳糖苷(2)、槲皮素(3)、槲皮素-3-O-β-D-吡喃半乳糖苷(4)、(-)-表没食子儿茶素(5)、(-)-表没食子儿茶素-3-没食子酸酯(6)、(-)-表没食子儿茶素-3-(3″-O-甲基)没食子酸酯(7)、杨梅素-3-O-β-D-吡喃半乳糖苷(8)、杨梅素-3-O-(6″-O-没食子酰基)-β-D-吡喃半乳糖苷(9)、杨梅素-3-O-α-L-吡喃鼠李糖苷(10)、杨梅素-3-O-(2″-O-没食子酰基)-α-L-吡喃鼠李糖苷(11)、杨梅素-3-O-(3″-O-没食子酰基)-α-L-吡喃鼠李糖苷(12)和杨梅素-3-O-α-L-吡喃阿拉伯糖苷(13)。除4、8和10号化合物外,所有化合物均首次从该植物中报道。
具有没食子酰基取代基的杨梅素糖苷(9、11和12)对肝星状细胞的增殖显示出最有效的抑制作用。
在本研究中,我们已从[植物名称]的生物活性部分成功分离出13种化合物。已充分阐明分离出的化合物的结构,并通过测量对正在增殖的肝星状细胞的抑制作用,评估了化合物对肝纤维化的肝脏保护活性。此外,已开发出使用HPLC对[植物名称]生物活性乙酸乙酯部分进行同步分析的方法。本文鉴定的10种化合物均首次从该植物中报道。HSQC:异核单量子相干;HMBC:异核多键相关;NOESY:核Overhauser效应光谱;EGCG:表没食子儿茶素-3-没食子酸酯;EGC:表没食子儿茶素;HSC:肝星状细胞;MTT:3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐